NIO INC - ADR (NIO)

US62914V1061 - ADR

4.4932  -0.05 (-1.03%)

Fundamental Rating

2

Overall NIO gets a fundamental rating of 2 out of 10. We evaluated NIO against 42 industry peers in the Automobiles industry. Both the profitability and financial health of NIO have multiple concerns. NIO is valied quite expensively at the moment, while it does show a decent growth rate.



1

1. Profitability

1.1 Basic Checks

In the past year NIO has reported negative net income.
NIO had negative earnings in each of the past 5 years.
The reported operating cash flow has been mixed in the past 5 years: NIO reported negative operating cash flow in multiple years.

1.2 Ratios

The Return On Assets of NIO (-20.31%) is comparable to the rest of the industry.
The Return On Equity of NIO (-186.12%) is worse than 69.05% of its industry peers.
Industry RankSector Rank
ROA -20.31%
ROE -186.12%
ROIC N/A
ROA(3y)-15.3%
ROA(5y)-26.89%
ROE(3y)-58.08%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A

1.3 Margins

Looking at the Gross Margin, with a value of 8.65%, NIO is in line with its industry, outperforming 45.24% of the companies in the same industry.
In the last couple of years the Gross Margin of NIO has declined.
The Profit Margin and Operating Margin are not available for NIO so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 8.65%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.91%
GM growth 5YN/A

1

2. Health

2.1 Basic Checks

NIO does not have a ROIC to compare to the WACC, probably because it is not profitable.
The number of shares outstanding for NIO has been increased compared to 1 year ago.
Compared to 5 years ago, NIO has more shares outstanding
Compared to 1 year ago, NIO has a worse debt to assets ratio.

2.2 Solvency

NIO has a Debt/Equity ratio of 1.52. This is a high value indicating a heavy dependency on external financing.
NIO has a worse Debt to Equity ratio (1.52) than 76.19% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.52
Debt/FCF N/A
Altman-Z N/A
ROIC/WACCN/A
WACC9.32%

2.3 Liquidity

NIO has a Current Ratio of 1.04. This is a normal value and indicates that NIO is financially healthy and should not expect problems in meeting its short term obligations.
NIO has a Current ratio of 1.04. This is in the lower half of the industry: NIO underperforms 71.43% of its industry peers.
NIO has a Quick Ratio of 1.04. This is a bad value and indicates that NIO is not financially healthy enough and could expect problems in meeting its short term obligations.
With a Quick ratio value of 0.93, NIO perfoms like the industry average, outperforming 45.24% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.04
Quick Ratio 0.93

6

3. Growth

3.1 Past

NIO shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 14.27%, which is quite good.
NIO shows quite a strong growth in Revenue. In the last year, the Revenue has grown by 15.67%.
The Revenue has been growing by 62.22% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)14.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.14%
Revenue 1Y (TTM)15.67%
Revenue growth 3Y50.68%
Revenue growth 5Y62.22%
Sales Q2Q%-2.06%

3.2 Future

Based on estimates for the next years, NIO will show a quite strong growth in Earnings Per Share. The EPS will grow by 16.20% on average per year.
The Revenue is expected to grow by 21.89% on average over the next years. This is a very strong growth
EPS Next Y13.55%
EPS Next 2Y13.54%
EPS Next 3Y14.03%
EPS Next 5Y16.2%
Revenue Next Year20.36%
Revenue Next 2Y32.66%
Revenue Next 3Y29.85%
Revenue Next 5Y21.89%

3.3 Evolution

Although the future Revenue growth is still strong, it is not able to hold up the even more excellent growth rate of the past years.

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NIO. In the last year negative earnings were reported.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for NIO. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A

4.3 Compensation for Growth

NIO's earnings are expected to grow with 14.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y13.54%
EPS Next 3Y14.03%

0

5. Dividend

5.1 Amount

NIO does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

NIO INC - ADR

NYSE:NIO (12/23/2024, 1:24:01 PM)

4.4932

-0.05 (-1.03%)

Chartmill FA Rating
GICS SectorConsumer Discretionary
GICS IndustryGroupAutomobiles & Components
GICS IndustryAutomobiles
Earnings (Last)11-20 2024-11-20/bmo
Earnings (Next)N/A N/A
Inst Owners15.5%
Inst Owner Change-34.67%
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap9.38B
Analysts75.15
Price Target6.84 (52.23%)
Short Float %10.35%
Short Ratio3.37
Dividend
Industry RankSector Rank
Dividend Yield N/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1.36%
Min EPS beat(2)1%
Max EPS beat(2)1.71%
EPS beat(4)2
Avg EPS beat(4)-5.96%
Min EPS beat(4)-18.12%
Max EPS beat(4)1.71%
EPS beat(8)2
Avg EPS beat(8)-14.23%
EPS beat(12)4
Avg EPS beat(12)-12.29%
EPS beat(16)5
Avg EPS beat(16)-40.41%
Revenue beat(2)0
Avg Revenue beat(2)-2.14%
Min Revenue beat(2)-3.67%
Max Revenue beat(2)-0.6%
Revenue beat(4)1
Avg Revenue beat(4)-2.34%
Min Revenue beat(4)-5.95%
Max Revenue beat(4)0.88%
Revenue beat(8)1
Avg Revenue beat(8)-7.05%
Revenue beat(12)5
Avg Revenue beat(12)-3.13%
Revenue beat(16)9
Avg Revenue beat(16)-0.83%
PT rev (1m)-10.1%
PT rev (3m)-15.47%
EPS NQ rev (1m)-6.4%
EPS NQ rev (3m)-16.87%
EPS NY rev (1m)-11.83%
EPS NY rev (3m)-9.31%
Revenue NQ rev (1m)-1.92%
Revenue NQ rev (3m)-9.38%
Revenue NY rev (1m)-7.01%
Revenue NY rev (3m)-2.9%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 1.08
P/FCF N/A
P/OCF N/A
P/B 6.03
P/tB 6.16
EV/EBITDA N/A
EPS(TTM)-1.31
EYN/A
EPS(NY)-1.06
Fwd EYN/A
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS4.14
BVpS0.74
TBVpS0.73
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -20.31%
ROE -186.12%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 8.65%
FCFM N/A
ROA(3y)-15.3%
ROA(5y)-26.89%
ROE(3y)-58.08%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-21.91%
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.61
Health
Industry RankSector Rank
Debt/Equity 1.52
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.04
Quick Ratio 0.93
Altman-Z N/A
F-ScoreN/A
WACC9.32%
ROIC/WACCN/A
Cap/Depr(3y)302.6%
Cap/Depr(5y)237.28%
Cap/Sales(3y)17.07%
Cap/Sales(5y)15.99%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)14.27%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%6.14%
EPS Next Y13.55%
EPS Next 2Y13.54%
EPS Next 3Y14.03%
EPS Next 5Y16.2%
Revenue 1Y (TTM)15.67%
Revenue growth 3Y50.68%
Revenue growth 5Y62.22%
Sales Q2Q%-2.06%
Revenue Next Year20.36%
Revenue Next 2Y32.66%
Revenue Next 3Y29.85%
Revenue Next 5Y21.89%
EBIT growth 1Y1.32%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year27.24%
EBIT Next 3Y21.79%
EBIT Next 5Y19.8%
FCF growth 1Y-45.06%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y64.26%
OCF growth 3YN/A
OCF growth 5YN/A